Use of mouse liver tumor data in risk assessments performed by the U.S. Environmental Protection Agency
- PMID: 2179964
Use of mouse liver tumor data in risk assessments performed by the U.S. Environmental Protection Agency
Abstract
In summary, the EPA has begun to look critically at the induction of certain types of tumors in certain species, including liver tumors in mice. The controversy over the use of such tumor data in assessing the cancer risk for humans has been going on for some time. The present agency policy is to downgrade the weight of evidence for such data under certain conditions. Review of the cancer risk assessments for the 109 chemicals that the agency has formally verified shows that a variety of chemicals yield liver tumors in mice. However, one group of substances that consistently produced such tumors was chlorinated compounds (84%). Many of these compounds not only induced liver tumors in mice but also induced liver tumors in rats and/or other types of tumors in mice and rats. However, several of the chlorinated compounds produced only mouse liver tumors. Another group of compounds that often induced liver tumors in mice was nitrogen-containing compounds (aromatic amines, hydrazines, nitrosamines). These latter substances tended to not only induce liver tumors in mice but also a variety of other tumor types in a variety of species. Mouse liver tumor data have played a major role in the classification of substances in categories B2 and C. Fifty-six percent of the chemicals in category B2 and 40% in category C were classified based at least partially on the use of mouse liver tumor data. In addition, 21 of the 29 category B2 chemicals that produced liver tumors in mice and 5 of the 8 category C chemicals are chlorinated compounds. These two results indicate the importance of chlorinated compounds to the agency, and therefore, the importance of mouse liver tumor data in agency cancer risk assessments.
Similar articles
-
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57. doi: 10.1006/rtph.1999.1296. Regul Toxicol Pharmacol. 1999. PMID: 10388618 Review.
-
Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?Regul Toxicol Pharmacol. 2005 Mar;41(2):128-33. doi: 10.1016/j.yrtph.2004.11.001. Epub 2004 Dec 19. Regul Toxicol Pharmacol. 2005. PMID: 15698536
-
Chloroform mode of action: implications for cancer risk assessment.Regul Toxicol Pharmacol. 1997 Oct;26(2):142-55. doi: 10.1006/rtph.1997.1161. Regul Toxicol Pharmacol. 1997. PMID: 9356278 Review.
-
Liver tumor promoters and other mouse liver carcinogens.Prog Clin Biol Res. 1990;331:85-108. Prog Clin Biol Res. 1990. PMID: 2179967 Review.
-
Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.Regul Toxicol Pharmacol. 1994 Apr;19(2):183-201. doi: 10.1006/rtph.1994.1017. Regul Toxicol Pharmacol. 1994. PMID: 8041916 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials